Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children’s Oncology Group Studies P9904 and P9905-Reference-Cited by-同舟云学术

Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children’s Oncology Group Studies P9904 and P9905

Published:2019-11-14 Issue:4 Volume:34 Page:1006-1016
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Winick Naomi^ORCID,Martin Paul L.,Devidas Meenakshi,Shuster Jonathan,Borowitz Michael J.,Paul Bowman W.,Larsen Eric,Pullen Jeanette,Carroll Andrew,Willman Cheryl,Hunger Stephen P.,Carroll William L.,Camitta Bruce M.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0642-2.pdf

Reference43 articles.

1. Pui C, Robison LL, Look AT. Acute lymphoblastic leukemia. Lancet. 2008;371:1030–43.

2. O’Leary M, Krailo M, Anderson JR, Reaman GH. Progress in childhood cancer: 50 years of research collaboration, a report from the Children’s Oncology Group. Semin Oncol. 2008;35:484–93.

3. Stanulla M, Schrappe M. Treatment of childhood acute lymphoblastic leukemia. Semin Hematol. 2009;46:52–63.

4. Farber S, Diamond LK, Mercer RD. Temporary remissions in acute leukemia in children produced by folic acid antagonist 4-aminopteroylglutamic acid (aminopterin). New Engl J Med. 1948;238:787–93.

5. Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia. 2000;14:2267–75.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study;Leukemia;2024-09-11

2. Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia;Pediatric Blood & Cancer;2023-07-25

3. Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932;Leukemia;2023-03-25

4. Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia;Blood Advances;2022-12-28

5. Folate Antagonists;Holland‐Frei Cancer Medicine;2022-10-21